SCHEDULE 13D: Activist Investors Radoff and Torok Group to Push for Strategic Review and Board Refresh at Alto Ingredients

A group of activist investors, including Bradley L. Radoff and Michael Torok, have formed a group to collectively own 6.4% of Alto Ingredients, Inc. and intend to push for a strategic review, including a potential sale of the company, and a significant refresh of its Board of Directors.

Summary

• The Radoff Family Foundation, Bradley L. Radoff, JEC II Associates, LLC, and Michael Torok (collectively, the "Reporting Persons") have formed a group to collectively beneficially own 4,925,000 shares of Alto Ingredients, Inc. common stock, representing approximately 6.4% of the outstanding shares as of November 7, 2024.
• The Reporting Persons acquired these shares because they believe they were undervalued and represented an attractive investment opportunity.
• They assert that Alto Ingredients' Board of Directors has failed to manage the company's assets profitably.
• The group intends to advocate for the Board to immediately commence a strategic review process, including a potential sale of the Issuer.
• They also demand a "meaningful refresh" of the Board, specifically calling for the retirement of Chairman Douglas L. Kieta (a director since 2006, at least 81 years old) and Michael D. Kandris (a director since 2008, at least 76 years old).
• If the Board does not announce a meaningful refresh, the Reporting Persons plan to vote their shares against the re-election of all current directors at the 2025 annual meeting and may nominate a competing slate of director candidates.
• The Reporting Persons intend to discuss their views with the Issuer and market participants ahead of the 2025 Annual Meeting.
• They may also engage in further actions such as discussions with potential acquirers, proposals concerning capital allocation, capitalization, ownership structure, and operations.

Sentiment

Score: 4

Explanation: The filing indicates significant dissatisfaction from a group of investors regarding Alto Ingredients' current management and strategic direction, specifically citing a failure to manage assets profitably and demanding a strategic review and board refresh. This signals potential for corporate upheaval and a proxy contest, which introduces uncertainty but also the possibility of value-enhancing changes.

Positives

• Reporting Persons believe Alto Ingredients shares were undervalued and represent an attractive investment opportunity.
• The formation of an activist group could potentially drive strategic changes that unlock shareholder value, such as a strategic review or sale of the company.
• The group's intent to engage with management and other stakeholders could lead to improved corporate governance and operational efficiency.

Negatives

• The Reporting Persons explicitly state their belief that the Issuer's Board of Directors has "failed to demonstrate that it can manage the Issuer's assets profitably," indicating significant dissatisfaction with current management.
• The threat of a proxy contest at the 2025 annual meeting suggests potential for disruption and uncertainty within the company.
• The call for the retirement of long-serving directors highlights concerns about board independence and effectiveness.

Risks

• Proxy Contest: The Reporting Persons intend to vote against current directors and may nominate their own slate, leading to a potentially costly and distracting proxy contest.
• Management Instability: The activist campaign could lead to significant changes in the Board and potentially management, creating uncertainty.
• Strategic Review Outcome: While a strategic review could be positive, there is no guarantee it will result in a favorable outcome or a sale at an attractive valuation.
• Share Price Volatility: Activist campaigns often lead to increased share price volatility as the market reacts to potential changes.
• Execution Risk: Even if new management or a new strategy is implemented, there is always a risk that it may not achieve the desired results.

Future Outlook

The Reporting Persons intend to actively engage with Alto Ingredients' management and Board to advocate for a strategic review, including a potential sale of the company, and a significant refresh of the Board of Directors. If their demands for board changes are not met, they plan to initiate a proxy contest at the 2025 annual meeting by voting against current directors and potentially nominating their own slate of candidates. Their future actions may also include further purchases or sales of shares, discussions with potential acquirers, and proposals regarding the company's capital allocation, ownership structure, and operations.

Management Comments

• "The Reporting Persons purchased the Shares based on the Reporting Persons' belief that the Shares, when purchased, were undervalued and represented an attractive investment opportunity."
• "The Reporting Persons believe that the Issuer's Board of Directors... has failed to demonstrate that it can manage the Issuer's assets profitably."
• "In the Reporting Persons' view, the best outcome for stockholders would be for the Board to immediately commence a strategic review process, including a potential sale of the Issuer."
• "Unless the Board announces a meaningful refresh, including the retirements of Chairman Douglas L. Kieta... and Michael D. Kandris..., the Reporting Persons intend to vote their Shares against the reelection of all directors currently serving on the Board at the Issuer's 2025 annual meeting of stockholders and may nominate a competing slate of director candidates at such meeting."

Industry Context

This Schedule 13D filing indicates an activist investor campaign targeting Alto Ingredients, Inc., a company likely operating in the biofuels or specialty alcohol industry given its name. Activist campaigns are a common feature in industries where companies may be perceived as underperforming, undervalued, or having suboptimal corporate governance. Such campaigns often aim to unlock shareholder value through strategic changes, asset sales, or improved operational efficiency, reflecting a broader trend of increased shareholder engagement and demand for accountability from corporate boards.

Comparison to Industry Standards

• The document does not provide specific financial or operational metrics for Alto Ingredients that would allow for a direct comparison to industry standards or specific comparable companies/projects.
• However, the activist investors' assertion that the Board has "failed to demonstrate that it can manage the Issuer's assets profitably" implies a perceived underperformance relative to industry peers or potential.
• The call for a strategic review and potential sale suggests that the investors believe the company's current valuation or operational strategy is not maximizing shareholder value, which is a common trigger for activist intervention when a company's performance lags behind industry benchmarks or investor expectations.

Management Changes

Corporate Governance

Related Party Transactions

• The Reporting Persons (The Radoff Family Foundation, Bradley L. Radoff, JEC II Associates, LLC, and Michael Torok) entered into a Group Agreement on February 24, 2025. This agreement formalizes their collaboration to coordinate activities with respect to Alto Ingredients, including joint Schedule 13D filings and pro rata sharing of expenses.

Stakeholder Impact

• Shareholders: Potential for increased shareholder value if the activist campaign leads to a successful strategic review or improved corporate governance. Conversely, a prolonged proxy contest could create uncertainty and negatively impact share price.
• Employees: A strategic review or potential sale of the company could lead to restructuring, layoffs, or changes in company culture and leadership.
• Management/Directors: Current Board members, particularly Douglas L. Kieta and Michael D. Kandris, face direct pressure for retirement and potential removal through a proxy contest. The entire management team may face increased scrutiny and potential changes.
• Creditors: A strategic review or sale could impact the company's financial structure and debt obligations, potentially affecting creditors.
• Customers/Suppliers: Changes in company strategy or ownership could affect existing business relationships, though the direct impact is not detailed in this filing.

Next Steps

• The Reporting Persons intend to discuss their views with Alto Ingredients and market participants in advance of the 2025 Annual Meeting.
• If the Board does not announce a "meaningful refresh" (including the retirement of specific directors), the Reporting Persons intend to vote against the re-election of all current directors at the 2025 Annual Meeting.
• The Reporting Persons may nominate a competing slate of director candidates at the 2025 Annual Meeting.
• The Reporting Persons may increase or decrease their position in Alto Ingredients shares.
• Future actions could include engaging in communications with management and the Board, discussions with stockholders or third parties (including potential acquirers), and making proposals concerning capital allocation, capitalization, ownership structure (including a sale), Board structure, or operations.

Key Dates

Keywords

Alto Ingredients, ALTO, Schedule 13D, activist investor, Bradley L. Radoff, Michael Torok, corporate governance, strategic review, company sale, board refresh, proxy contest, shareholder activism, undervalued stock